Anfarm Hellas S.A. - Main Component
Active Substance | Strength | Form |
---|---|---|
DalbavancinUnder Development | 500mg/vial | Pd.C.So.In |
Daptomycin | 350mg/Vial, 500mg/Vial | Pd.I.S.Inf |
Digoxin | 0.25mg/ml (Ampx2ml) | Inj.Sol |
Donepezil HCl | 5mg, 10mg | F.C.Tab |
Dopamine HCl | 10mg/ml (Ampx5ml) | C/S.Sol.In |
Active Substance | Strength | Form |
---|---|---|
DalbavancinUnder Development | 500mg/vial | Pd.C.So.In |
Daptomycin | 350mg/Vial, 500mg/Vial | Pd.I.S.Inf |
Digoxin | 0.25mg/ml (Ampx2ml) | Inj.Sol |
Donepezil HCl | 5mg, 10mg | F.C.Tab |
Dopamine HCl | 10mg/ml (Ampx5ml) | C/S.Sol.In |
Active Substance | Strength | Form | Market Availability |
---|---|---|---|
DalbavancinUnder Development | 500mg/vial | Pd.C.So.In | Q1 2024 |
Daptomycin | 350mg/Vial, 500mg/Vial | Pd.I.S.Inf | International |
Digoxin | 0.25mg/ml (Ampx2ml) | Inj.Sol | Selected Markets |
Donepezil HCl | 5mg, 10mg | F.C.Tab | Selected Markets |
Dopamine HCl | 10mg/ml (Ampx5ml) | C/S.Sol.In | Selected Markets |